Angina Pectoris

• 

  Subject Areas on Research

  • 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. 
  • 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. 
  • 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. 
  • A 69-year-old man with anger and angina. 
  • A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy. Outcomes of a randomized clinical trial. Veterans Affairs Study of Angioplasty Compared to Medical Therapy Investigators. 
  • A comparison of sublingual nifedipine versus nitroglycerin in the treatment of acute angina pectoris. 
  • Access site for cardiac catheterization. 
  • Acute results, complications, and effect of lesion characteristics on outcome with the solid-state, pulsed-wave, mid-infrared laser angioplasty system: final multicenter registry report. Holmium:YAG Laser Multicenter Investigators. 
  • Aggressive clinical pattern of angina at restenosis following coronary angioplasty in unstable angina. 
  • American College of Emergency Physicians information paper: chest pain units in emergency departments--a report from the Short-Term Observation Services Section. 
  • Aminophylline for angina pectoris. Boon or bust? 
  • Amlodipine in chronic heart failure. 
  • Analysis of the components of CHD risk in the Framingham study: new multivariate procedures for the analysis of chronic disease development. 
  • Anatomic and prognostic implications of an early positive treadmill exercise test. 
  • Angina frequency after myocardial infarction and quality of life in older versus younger adults: the Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study. 
  • Angina pectoris in type A and type B cardiac patients. 
  • Angina, myocardial ischemia and coronary disease: gold standards, operational definitions and correlations. 
  • Angiographic follow-up after internal mammary artery graft angioplasty. 
  • Angiographic morphology in unstable angina pectoris. 
  • Antianginal effects of intravenous nitroglycerin over 24 hours. 
  • Antianginal medications and long-term outcomes after elective catheterization in patients with coronary artery disease. 
  • Aortic subannular left ventricular aneurysm: a rare and surgically correctable cause of angina. 
  • Aorto-coronary bypass graft surgery in a patient on home hemodialysis. 
  • Applying the resource-based relative value scale to the Emory angioplasty versus surgery trial. 
  • Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention. 
  • Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification. 
  • Assessment of ventricular function in coronary artery disease by means of atrial pacing and exercise. 
  • Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study. 
  • Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials. 
  • Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. 
  • Baseline characteristics and therapeutic goals in the New Approaches to Coronary Intervention (NACI) registry. 
  • Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. 
  • CASS in retrospect: lessons from the randomized cohort and registry. Coronary Artery Surgery Study. 
  • CD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina. 
  • Cardiac markers in the assessment of acute coronary syndromes. 
  • Care of the patient with cardiovascular disease undergoing general surgery. 
  • Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease. 
  • Change in Angina Symptom Status After Acute Myocardial Infarction and Its Association With Readmission Risk: An Analysis of the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) Registry. 
  • Chelation therapy and cardiovascular outcomes--in reply. 
  • Chest pain in patients with heart failure: why history may matter. 
  • Chest pain in women. 
  • Chest pain self-management training for patients with coronary artery disease. 
  • Chronic stable angina monotherapy. Nifedipine versus propranolol. 
  • Clinical Effectiveness of Cardiac Noninvasive Diagnostic Testing in Outpatients Evaluated for Stable Coronary Artery Disease. 
  • Clinical and Angiographic Predictors of Patient-Reported Angina 1 Year After Coronary Artery Bypass Graft Surgery. 
  • Clinical characteristics and current management of medically refractory unstable angina. 
  • Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme. 
  • Clinical correlates and prognostic significance of type A behavior and silent myocardial ischemia on the treadmill. 
  • Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty. 
  • Clinical study of the cardiac findings in patients on chronic maintenance hemodialysis: the relationship to coronary risk factors. 
  • Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. 
  • Combinations of beta-blockers and calcium channel blockers: a cause of malignant perioperative conduction disturbances? 
  • Comparative prognostic significance of simultaneous versus independent resolution of ST segment depression relative to ST segment elevation during acute myocardial infarction. 
  • Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Comparison of high-dose and medium-dose propranolol in the relief of exercise-induced myocardial ischemia. 
  • Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise. 
  • Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. 
  • Complete and incomplete revascularization at aortocoronary bypass surgery: experience with 392 consecutive patients. 
  • Components of Type A, hostility, and anger-in: relationship to angiographic findings. 
  • Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA. 
  • Connecting the pieces of the cardiovascular care puzzle in Canada. 
  • Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials. 
  • Converting i.v. nitroglycerin therapy to nitroglycerin ointment therapy: a comparison of two methods. 
  • Coronary bypass surgery in chronic stable angina. 
  • Coronary flow and regional function before and after supraarterial myotomy for myocardial bridging. 
  • Coronary steal from a left internal mammary artery coronary bypass graft by a left upper extremity arteriovenous hemodialysis fistula. 
  • Current status of cardiac surgery in the abciximab-treated patient. 
  • Cyclic coronary flow: defining preinfarction angina at the crossroads of unstable angina and myocardial infarction. 
  • Dealing with the highs and lows of contrast agents in left main disease. 
  • Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes. 
  • Differential Outcomes With Edetate Disodium-Based Treatment Among Stable Post Anterior vs. Non-Anterior Myocardial Infarction Patients. 
  • Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. 
  • Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina? 
  • Does ranolazine have a place in the treatment of acute coronary syndromes? 
  • Does the electrocardiographic pattern of "anteroseptal" myocardial infarction correlate with the anatomic location of myocardial injury? 
  • Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. 
  • Early versus delayed invasive intervention in acute coronary syndromes. 
  • Early versus delayed, provisional eptifibatide in acute coronary syndromes. 
  • Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial. 
  • Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease. 
  • Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. 
  • Effect of gender on angioplasty outcome: are we closer to the answer? 
  • Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. 
  • Effect of the Presence and Type of Angina on Cardiovascular Events in Patients Without Known Coronary Artery Disease Referred for Elective Coronary Angiography. 
  • Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial. 
  • Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. 
  • Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation. 
  • Effects of obesity on noninvasive test results in patients with suspected cardiac ischemia: Insights from the PROMISE trial. 
  • Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing. 
  • Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. 
  • Emerging clinical applications of electrical stimulation: opportunities for restoration of function. 
  • Emotional responsivity and transient myocardial ischemia. 
  • Enhanced External Counterpulsation (EECP): enough evidence to support this and the next wave? 
  • Enhanced external counterpulsation in the management of patients with cardiovascular disease. 
  • Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. 
  • Enoxaparin vs unfractionated heparin in acute coronary syndrome. 
  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. 
  • Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations. 
  • Estimating the likelihood of significant coronary artery disease. 
  • Exercise radionuclide angiocardiography predicts cardiac death in patients with coronary artery disease. 
  • Exercise stress testing in evaluation of aortocoronary bypass surgery. Report of 123 patients. 
  • Exercise treadmill score for predicting prognosis in coronary artery disease. 
  • Exercise treadmill testing is a poor predictor of anatomic restenosis after angioplasty for acute myocardial infarction. 
  • Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. 
  • Frequency of transient reductions in left ventricular ejection fraction at rest in coronary artery disease. 
  • Fusion of the left aortic cusp to the aoic wall with occlusion of the left coronary ostium, and aortic stenosis and insufficiency. 
  • Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease. 
  • Graded exercise stress tests in angiographically documented coronary artery disease. 
  • Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. 
  • Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease). 
  • Histopathologic examination of material from angioplasty balloon catheters used in vivo in human coronary arteries. 
  • Hostility, CHD incidence, and total mortality: a 25-year follow-up study of 255 physicians. 
  • Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial. 
  • Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. 
  • Implications and challenges using practice guidelines for chronic angina. 
  • Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. 
  • Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. 
  • Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry. 
  • Incidence and clinical significance of cardiac biomarker elevation during stem cell mobilization, apheresis, and intramyocardial delivery: an analysis from ACT34-CMI. 
  • Influence of racial disparities in procedure use on functional status outcomes among patients with coronary artery disease. 
  • Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. 
  • Intramyocardial, autologous CD34+ cell therapy for refractory angina. 
  • Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial. 
  • Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease. 
  • Isosorbide and isorbide dinitrate. 
  • Juvenile idiopathic arthritis and future risk for cardiovascular disease: a multicenter study. 
  • Left arm pain isn't always angina. 
  • Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease. 
  • Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study. 
  • Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. 
  • Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization. 
  • Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study. 
  • Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study. 
  • Myocardial ischemia in constrictive pericarditis. 
  • Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. 
  • Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study Group. 
  • Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. 
  • Outcome in one-vessel coronary artery disease. 
  • Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial. 
  • Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. 
  • Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. 
  • Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. 
  • Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes. 
  • Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). 
  • Percutaneous coronary revascularisation: is it ever worth what it costs? 
  • Percutaneous transluminal coronary angioplasty as palliation for patients considered poor surgical candidates. 
  • Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris. 
  • Percutaneous transluminal coronary angioplasty in women compared with men. 
  • Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. 
  • Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events. 
  • Pharmacological and emerging therapies in the treatment of chronic angina. 
  • Potential relief for refractory angina. 
  • Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers. 
  • Pre-hospital synthesized 12-lead ECG ischemia monitoring with trans-telephonic transmission in acute coronary syndromes: pilot study results of the ST SMART trial. 
  • Predictors of Physician Under-Recognition of Angina in Outpatients With Stable Coronary Artery Disease. 
  • Predictors of long-term clinical endpoints in patients with refractory angina. 
  • Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. 
  • Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. 
  • Prevalence and risk factors of retinal arteriolar emboli: the Singapore Malay Eye Study. 
  • Prinzmetal's angina, normal coronary arteries and pericarditis. 
  • Procainamide-induced sinus node dysfunction in patients with chronic renal failure. 
  • Profile of chronic and recurrent angina pectoris in a referral population. 
  • Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography. 
  • Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). 
  • Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial. 
  • Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease. 
  • Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. 
  • Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy. 
  • Psychosocial and physical predictors of anginal pain relief with medical management. 
  • Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. 
  • Quality of life after coronary revascularization in the United States and Canada. 
  • Quality of life after late invasive therapy for occluded arteries. 
  • Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. 
  • Quantitative and qualitative ST segment monitoring during and after percutaneous transluminal coronary angioplasty. 
  • Race and Sex Differences in Post-Myocardial Infarction Angina Frequency and Risk of 1-Year Unplanned Rehospitalization. 
  • Racial differences in long-term outcomes among black and white patients with drug-eluting stents. 
  • Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial. 
  • Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME). 
  • Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. 
  • Recovery of systolic and diastolic left ventricular function after a 60-second coronary arterial occlusion during percutaneous transluminal coronary angioplasty for angina pectoris. 
  • Reducing the influence of anecdotal reasoning on people's health care decisions: is a picture worth a thousand statistics? 
  • Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. 
  • Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION). 
  • Relation of platelet activation and myocardial ischemia biomarkers dependent on type of chest pain (abrupt onset versus intermittent) in patients with angina pectoris or non-Q-wave acute myocardial infarction. 
  • Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris. 
  • Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. 
  • Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Repeat Cell Therapy for Refractory Angina: Déjà vu All Over Again? 
  • Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. 
  • Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD. 
  • Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. American College of Cardiology. 
  • Revisiting the Canadian Cardiovascular Society grading of stable angina pectoris after a quarter of a century of use. 
  • Risk factors in coronary artery bypass surgery. 
  • Role of resting thallium201 perfusion in predicting coronary anatomy, left ventricular wall motion, and hospital outcome in unstable angina pectoris. 
  • ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. 
  • Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. 
  • Safety of coronary CT angiography and functional testing for stable chest pain in the PROMISE trial: A randomized comparison of test complications, incidental findings, and radiation dose. 
  • Safety of nifedipine in angina pectoris: a meta-analysis. 
  • Self-report of chest pain symptoms and coronary artery disease in patients undergoing angiography. 
  • Serial changes in left ventricular ejection fraction in the early hours after aortocoronary bypass grafting. 
  • Serial thallium-201 imaging at rest in patients with unstable and stable angina pectoris: relationship of myocardial perfusion at rest to presenting clinical syndrome. 
  • Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial. 
  • Should we cross the valve: the risk of retrograde catheterization of the left ventricle in patients with aortic stenosis. 
  • Stent thrombosis: role of compliance and nonresponsiveness to antiplatelet therapy. 
  • Surgical survival benefits for coronary disease patients with left ventricular dysfunction. 
  • Sympathectomy in the treatment of angina and arrhythmias. 
  • Systemic air embolism during off-pump coronary artery bypass surgery. 
  • The "Hassle Factor": what motivates physicians to manipulate reimbursement rules? 
  • The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. 
  • The aorta wall of patients presenting to the emergency department with acute myocardial infarction by cardiac magnetic resonance. 
  • The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee. 
  • The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. 
  • The effect of PEEP on left ventricular diastolic dimensions and systolic performance following myocardial revascularization. 
  • The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). 
  • The effects of neurokinin A, neurokinin B, and eledoisin on substance P analysis. 
  • The evaluation of chest pain in women. 
  • The healthy diver: A cross-sectional survey to evaluate the health status of recreational scuba diver members of Divers Alert Network (DAN). 
  • The inclusion of patient testimonials in decision aids: effects on treatment choices. 
  • The influence of age on health status outcomes after acute myocardial infarction. 
  • The influence of changes in blood volume on angina pectoris. A study of the effect of phlebotomy. 
  • The influence of time on the response to dopamine after coronary artery bypass grafting: assessment of left ventricular performance and contractility using pressure/dimension analyses. 
  • The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. 
  • The natural history and recommended management of patients with traumatic coronary artery fistulas. 
  • The nature of treatment selection in coronary artery disease. Experience with medical and surgical treatment of a chronic disease. 
  • The prognosis for patients with new-onset angina who have undergone cardiac catheterization. 
  • The spectrum of unstable angina: prognostic role of serum creatine kinase determination. 
  • Therapeutic Approaches for the No-Option Refractory Angina Patient. 
  • Therapeutic goals in patients with refractory chronic angina. 
  • Tolerance to organic nitrates: clinical and experimental perspectives. 
  • Transient platelet aggregation as a mechanism of unstable angina. Aggressive treatment with coronary angioplasty. 
  • Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis. 
  • Transmyocardial laser revascularization for inoperable coronary artery disease. 
  • Transmyocardial laser revascularization: experimental and clinical results. 
  • Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice. 
  • Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. 
  • Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. 
  • Troponin and other cardiac markers: role in management of acute coronary syndromes. 
  • Ultrasound assessment of left ventricular function following aortocoronary saphenous vein bypass grafting. 
  • Use of multidetector computed tomography for the assessment of acute chest pain: a consensus statement of the North American Society of Cardiac Imaging and the European Society of Cardiac Radiology. 
  • Use of multidetector computed tomography for the assessment of acute chest pain: a consensus statement of the North American Society of Cardiac Imaging and the European Society of Cardiac Radiology. 
  • Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial. 
  • Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. 
  • Usefulness of exercise electrocardiography and thallium scintigraphy in unstable angina pectoris in predicting the extent and severity of coronary artery disease. 
  • Utility of High-Sensitivity Troponin Among Stable Patients With Chest Pain Undergoing Stress Imaging (from PROMISE). 
  • Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. 
  • Value of the history and physical in identifying patients at increased risk for coronary artery disease. 
  • Vascular factors predict rate of progression in Alzheimer disease. 
  • When is angina good? Preconditioning in acute myocardial infarction. 
  • Which is the true channel? 
• 

  Keywords of People

  • Granger, Christopher Bull, Professor of Medicine, School of Nursing
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology